Project Grant R21EY035712
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $393K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Akron, OH 44308, USA
Similar Awards
- This $745,607 Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of the RETIVUE ENTIREEYE, a handheld, high-resolution, non-contact, single-image, widefield retinal screening camera for premature and healthy newborn babies. The device utilizes a novel all-digital, no moving parts scanning light module to capture a seamless, high-quality, diagnostic ultra-widefield image of the entire baby eye in a single shot. This technology has the...
- This $735,937 Project Grant, awarded by the National Eye Institute (CFDA 93.867 - Vision Research), aims to test the effectiveness of a technology-based approach to screening for glaucoma and other eye diseases at Federally Qualified Health Centers (FQHCs). The University of Michigan, as the primary awardee, will utilize digital ophthalmic data captured by FQHC technicians to help eye doctors at the FQHCs triage patients to appropriate care, including 30-minute detailed visits or 10-minute...
- This Project Grant award of $638,837, provided by the National Eye Institute under the Vision Research federal grant program (CFDA 93.867), aims to (1) develop an early screening algorithm for the detection of cerebral visual impairment (CVI) in infants and (2) establish neurodevelopmental profiles to inform interventions for young children diagnosed with CVI. The research is being conducted by the Children's Hospital Medical Center in Cincinnati, Ohio. The overarching goal is to enable early...
- This Project Grant award of $493,642, provided by the National Eye Institute (CFDA 93.867 - Vision Research), supports a research project to identify and locate geographic clusters of vision and eye health problems using secondary surveillance data. The key products and services to be delivered under this award include: Developing an application to access public use files from the CDC-funded Vision and Eye Health Surveillance System (VEHSS) to conduct scan statistical analyses and report...
- This federal Project Grant award of $306,118 was provided by the National Eye Institute (CFDA 93.867 - Vision Research) to Eyescreen, Inc. for the project "DRUG SCREENING PLATFORM IN THE LIGHT-RESPONSIVE HUMAN EYE". The goal of this award is to develop new technology and assays to test the efficacy and safety of investigational new drugs (INDs) for blinding diseases like age-related macular degeneration, diabetic retinopathy, glaucoma, and inherited retinal degenerations using...
- The National Eye Institute (NEI) awarded a $295,766 Project Grant (CFDA 93.867 - Vision Research) to Ther-Ai LLC, located in Oviedo, FL, to develop a smartphone application called ILIGN. The goal of this project is to create a rapid, non-invasive, and accurate artificial intelligence-driven system to pre-screen for ocular misalignment (strabismus), a leading cause of preventable blindness in children. The expected outcome is a software platform that allows untrained end-users to diagnose...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports the development of a novel, noninvasive, and sensitive diagnostic method to measure retinal dysfunction. The $491,466 award will fund research at the University of California, San Francisco (UCSF) from January 1, 2025 to December 31, 2026. The project aims to create a scalable diagnostic tool that can detect the earliest signs of retinal diseases like diabetic retinopathy and retinitis pigmentosa,...
- The National Eye Institute (NEI) awarded a $479,417 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Florida to conduct a longitudinal study on the development of infant visuocortical function and its relationship to cognitive outcomes. The 5-year project aims to: Characterize infant visuocortical function and developmental trajectories using measures such as visual evoked potentials, steady-state visual evoked potentials, electroencephalography,...
- The Project Grant award of $621,250 from the National Eye Institute's Vision Research program (CFDA 93.867) is supporting the development of a gaze-contingent AI-enabled low vision assistive technology (GALVAT) system. The project is being led by The Johns Hopkins University, in collaboration with the Chicago Lighthouse, Applied Universal Dynamics Corp, and the Illinois Institute of Technology. The goal is to reduce information overload for visually impaired users by defining a gaze-contingent...
- This federal Project Grant award of $494,418.00 from the National Eye Institute (CFDA 93.867 - Vision Research) will support research to investigate the role of the visual environment in the development of myopia, or nearsightedness. The key objectives are: Determine the anti-myopia effectiveness of different real-world visual scenes to understand how the visual environment impacts eye growth and refractive development. Develop improved "repeated low-level red light" therapies that...